Carisma Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Carisma Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q4 2019 to Q2 2024.
  • Carisma Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending June 30, 2024 was $219K, a 45.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $219K -$184K -45.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.63M +$2.42M +1134% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.51M Dec 31, 2023 10-K 2024-04-01
Q3 2023 $403K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $403K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $213K Mar 31, 2023 10-Q 2023-05-11
Q4 2020 $162K +$49K +43.4% Dec 31, 2020 10-K 2021-03-15
Q4 2019 $113K Dec 31, 2019 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.